[Research progress in toxicology of molecular targeted anticancer drugs]

Area of Science:

• Oncology
• Pharmacology
• Toxicology

Background:

• Traditional chemotherapy has limitations in effectiveness and high adverse reactions.
• Molecular targeted anticancer drugs represent a rapidly developing area in cancer treatment.
• Current targeted therapies can cause significant organ damage (heart, liver, lung) and side effects (e.g., hand-foot syndrome).

Purpose of the Study:

• To highlight the critical need for pharmaceutical toxicology research in evaluating molecular targeted anticancer drugs.
• To investigate the toxicity profiles of novel targeted anticancer agents.
• To explore mechanisms underlying drug-induced organ damage and adverse effects.

Main Methods:

• Review of current literature on targeted anticancer drug toxicities.
• Analysis of preclinical and clinical data on adverse events.
• Identification of key toxicological pathways and biomarkers.

Main Results:

• Molecular targeted drugs, while effective, exhibit specific organ toxicities.
• Adverse effects such as hand-foot syndrome are common and limit clinical use.
• Understanding toxicity mechanisms is essential for therapeutic development.

Conclusions:

• Targeted anticancer drug development necessitates thorough toxicological evaluation.
• Further research into toxicity mechanisms and prevention strategies is critical.
• Mitigating adverse effects will enhance the clinical application of targeted cancer therapies.